Form 8-K - Current report:
SEC Accession No. 0001193125-21-367037
Filing Date
2021-12-27
Accepted
2021-12-27 16:30:36
Documents
13
Period of Report
2021-12-27
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d264178d8k.htm   iXBRL 8-K 25291
2 EX-3.2 d264178dex32.htm EX-3.2 165207
  Complete submission text file 0001193125-21-367037.txt   358711

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lnth-20211227.xsd EX-101.SCH 2893
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lnth-20211227_lab.xml EX-101.LAB 18126
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lnth-20211227_pre.xml EX-101.PRE 11406
7 EXTRACTED XBRL INSTANCE DOCUMENT d264178d8k_htm.xml XML 3448
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36569 | Film No.: 211520915
SIC: 2835 In Vitro & In Vivo Diagnostic Substances